title: [Treatment in initial stage of VTEC infection].
abstract: Verocytotoxin producing Escherichia coli(VTEC) causes gastrointestinal infections worldwide. In at most 8% of the children in Japan who are infected with VTEC, hemolytic-uremic syndrome(HUS) develops soon after the onset of diarrhea. Treatment with antibiotics does not ameliorate VTEC infections, and in some studies from western countries, it has been associated with worse clinical outcomes. It was recently indicated in Japan that early administration of fosfomycin to the patients with VTEC infection can decrease the risk of HUS. Moreover, early administration of Synsorb-Pk with high affinity to verocytotoxin to the patients with gastrointestinal VTEC infection was demonstrated to decrease the incidence of very mild and mild HUS, but it did not decrease the risk of moderate and severe HUS. In the developing stage of HUS, intravenous administration of fluid and electrolytes should be determined cautiously to prevent hyponatremia and systemic congestion.
authors.affiliation: Department of Pediatrics, Graduate School of Medicine, University of Tokyo.
authors.forename: Takashi
authors.initials: T
authors.lastname: Igarashi
mesh_terms: D000818:Animals; D004573:Electrolytes / Q000008:administration & dosage; D004927:Escherichia coli Infections; D019453:Escherichia coli O157; D005440:Fluid Therapy; D005578:Fosfomycin / Q000008:administration & dosage; D005759:Gastroenteritis / Q000150:complications / Q000382:microbiology* / Q000628:therapy*; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007010:Hyponatremia / Q000209:etiology / Q000517:prevention & control; D017646:Organosilicon Compounds / Q000008:administration & dosage; D012306:Risk; D014312:Trisaccharides / Q000008:administration & dosage
chemical_list: D004573:Electrolytes; D017646:Organosilicon Compounds; C119238:SYNSORB Pk; D014312:Trisaccharides; D005578:Fosfomycin